News

RSV vaccines and nirsevimab tied to reduced RSV-linked hospitalization
Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...
HealthDay on MSN8h
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated ...
Vermont Business Magazine23h
VDH: COVID-19 impact keeps decreasing
Vermont has the second lowest state fatality rate in the US (147.2 per 100K; Hawaii 112.9/100K). Mississippi (464.7/100K) and ...
Pulmonology Advisor23h
ACIP Recommends RSV Vaccine for 50 to 59-Year-Olds at High Risk
ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.
Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution
MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...